Genetron $126 million going-private transaction
We are separately advising Genetron and the special committee of its board on the transaction
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Sirio Pharma acquisition of a majority stake of Best Formulations
We advised Sirio Pharma on the acquisition
Esco Aster spinoff transactions
We are advising Esco Lifesciences on the spinoff
InSilico Medicine $35 million Series D2 financing
We are advising InSilico Medicine on the financing
InSilico Medicine $60 million Series D financing
We are advising InSilico Medicine in connection with its $60 million Series D financing
Laekna Therapeutics $61 million Series D financing
We are advising Laekna Therapeutics in connection with its Series D financing
Yili Group HK$6.25 billion acquisition of 34.33% of Ausnutria Dairy
We advised Yili on the acquisition of a controlling interest in Ausnutria
Kingsoft Cloud acquisition of controlling interests in Camelot
We are advising Kingsoft Cloud in connection with the acquisition
Ingram Micro $7.2 billion acquisition by Platinum Equity
We advised Ingram Micro on the transaction
Yili Group HK$1.66 billion privatization of China ZhongDi Dairy
We advised Yili, the largest dairy company in China, on the takeover and delisting of ZhongDi from the HKEX